Patients with Citrulline Transport Defect may present with a variety of symptoms, often appearing in infancy or early childhood. Common symptoms include poor feeding, vomiting, lethargy, and developmental delays. In severe cases, it can lead to hyperammonemia, a condition characterized by elevated levels of ammonia in the blood, which can cause neurological damage if not treated promptly.

Diagnosing Citrulline Transport Defect involves a combination of clinical evaluation and laboratory tests. Blood tests are crucial to measure amino acid levels, particularly looking for elevated citrulline. Genetic testing can confirm the diagnosis by identifying mutations in the SLC25A13 gene, which is responsible for the transport of citrulline. Additional tests may include liver function tests and imaging studies to assess any organ involvement.

Treatment for Citrulline Transport Defect focuses on managing symptoms and preventing complications. Dietary modifications are essential, often involving a low-protein diet to reduce ammonia production. Supplements of specific amino acids may be necessary to compensate for deficiencies. In some cases, medications that help remove excess ammonia from the body are prescribed. Regular monitoring by a healthcare team is crucial to adjust treatment as needed.

The prognosis for individuals with Citrulline Transport Defect varies depending on the severity of the condition and the timeliness of treatment. With early diagnosis and appropriate management, many patients can lead relatively normal lives. However, untreated or severe cases can result in significant health challenges, including neurological impairment.

Citrulline Transport Defect is caused by mutations in the SLC25A13 gene, which provides instructions for making a protein involved in transporting citrulline across cell membranes. This genetic mutation is inherited in an autosomal recessive pattern, meaning a child must inherit two copies of the mutated gene, one from each parent, to be affected.

Citrulline Transport Defect is a rare condition, with a higher prevalence in certain populations, such as individuals of East Asian descent. The exact incidence is not well-documented due to its rarity, but it is considered a rare disorder worldwide.

The pathophysiology of Citrulline Transport Defect involves the disruption of the urea cycle, a series of biochemical reactions in the liver that convert ammonia to urea for excretion. The defect in citrulline transport leads to an accumulation of citrulline and ammonia, causing toxic effects, particularly on the brain, due to ammonia's neurotoxic properties.

Currently, there is no known way to prevent Citrulline Transport Defect, as it is a genetic condition. However, genetic counseling is recommended for families with a history of the disorder to understand the risks and consider testing options. Prenatal testing may be available for at-risk pregnancies.

Citrulline Transport Defect is a rare genetic disorder affecting amino acid transport, leading to a range of symptoms primarily due to ammonia buildup. Early diagnosis and management are crucial to prevent serious complications. Treatment involves dietary modifications and medications to manage symptoms and reduce ammonia levels.

For patients and families affected by Citrulline Transport Defect, understanding the condition is vital. It is a genetic disorder that can cause symptoms like poor feeding and developmental delays due to the body's inability to process certain amino acids properly. Management includes dietary changes and medications to control symptoms and prevent complications. Regular follow-up with healthcare providers is essential to ensure optimal care and quality of life.